Literature DB >> 8314841

The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression.

O Lefebvre1, C Wolf, M Kédinger, M P Chenard, C Tomasetto, P Chambon, M C Rio.   

Abstract

We have previously shown that the human pS2 gene, which codes for a secreted peptide of 60 amino acids, is expressed in a number of human carcinomas, including carcinomas of the breast, the pancreas, and the large bowel. Strong pS2 gene expression was also observed in the normal gastric mucosa and in the regenerative tissues surrounding ulcerous lesions of the gastrointestinal tract. A number of pS2 similar peptides, designated as P-domain peptides, have been described, notably the porcine (PSP), murine (mSP), and human (hSP) spasmolytic polypeptides, which correspond to duplicated pS2 proteins. We have now cloned a mouse homolog of the human pS2 cDNA to dispose of an animal model to study the pS2 protein function, which remains unknown at the present time. We show that the mouse putative pS2 protein sequence and the physiological pattern of expression of the mouse pS2 gene are well conserved. The mouse pS2 gene is highly expressed in the stomach mucosa cells, whereas no pS2 gene expression could be detected in the mouse mammary gland, even during postnatal development processes dependent on growth factors or hormones. Using in situ hybridization, we show that although coexpressed in the fundus, the antrum and the antrum-pyloric regions of the stomach, the mouse pS2 and mSP genes exhibit distinct and complementary cellular patterns of expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314841      PMCID: PMC2119609          DOI: 10.1083/jcb.122.1.191

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  50 in total

1.  1H NMR-based determination of the secondary structure of porcine pancreatic spasmolytic polypeptide: one of a new family of "trefoil" motif containing cell growth factors.

Authors:  M D Carr
Journal:  Biochemistry       Date:  1992-02-25       Impact factor: 3.162

2.  Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis.

Authors:  R L Ceriani; C M Chan; F S Baratta; L Ozzello; C M DeRosa; D V Habif
Journal:  Int J Cancer       Date:  1992-05-28       Impact factor: 7.396

Review 3.  Multiple hormone interactions in the developmental biology of the mammary gland.

Authors:  Y J Topper; C S Freeman
Journal:  Physiol Rev       Date:  1980-10       Impact factor: 37.312

4.  Expression of the pS2 gene in normal, benign and neoplastic human stomach.

Authors:  Y Luqmani; C Bennett; I Paterson; C M Corbishley; M C Rio; P Chambon; G Ryall
Journal:  Int J Cancer       Date:  1989-11-15       Impact factor: 7.396

5.  xP2, a new member of the P-domain peptide family of potential growth factors, is synthesized in Xenopus laevis skin.

Authors:  F Hauser; C Roeben; W Hoffmann
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

6.  Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors, and normal breast tissues. Correlation with prognosis and adjuvant hormone therapy.

Authors:  J Predine; F Spyratos; J F Prud'homme; C Andrieu; K Hacene; M Brunet; C Pallud; E Milgrom
Journal:  Cancer       Date:  1992-04-15       Impact factor: 6.860

7.  Pancreatic spasmolytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects.

Authors:  K D Jørgensen; B Diamant; K H Jørgensen; L Thim
Journal:  Regul Pept       Date:  1982-03

8.  Immunohistochemical localization of pancreatic spasmolytic polypeptide (PSP) in the pig.

Authors:  T N Rasmussen; L Raaberg; S S Poulsen; L Thim; J J Holst
Journal:  Histochemistry       Date:  1992-09

Review 9.  Mucins: structure, function, and associations with malignancy.

Authors:  P L Devine; I F McKenzie
Journal:  Bioessays       Date:  1992-09       Impact factor: 4.345

10.  Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development.

Authors:  S D Robinson; G B Silberstein; A B Roberts; K C Flanders; C W Daniel
Journal:  Development       Date:  1991-11       Impact factor: 6.868

View more
  31 in total

1.  The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach.

Authors:  J L Newton; A Allen; B R Westley; F E May
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

2.  The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation.

Authors:  D Taupin; D C Wu; W K Jeon; K Devaney; T C Wang; D K Podolsky
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

3.  Amplification and invasiveness of epithelial progenitors during gastric carcinogenesis in trefoil factor 1 knockout mice.

Authors:  S M Karam; C Tomasetto; M-C Rio
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

4.  TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury.

Authors:  James J Farrell; Douglas Taupin; Theodore J Koh; Duan Chen; Chun-Mei Zhao; Daniel K Podolsky; Timothy C Wang
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  Anti-tumor efficacy evaluation of a novel monoclonal antibody targeting neutral amino acid transporter ASCT2 using patient-derived xenograft mouse models of gastric cancer.

Authors:  Noriyuki Kasai; Aya Sasakawa; Kenta Hosomi; Tze Wei Poh; Bernadette Lynn Chua; Wei Peng Yong; Jimmy So; Shing Leng Chan; Richie Soong; Koji Kono; Toshihiko Ishii; Kazuya Yamano
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

6.  Goblet-cell-specific transcription of mouse intestinal trefoil factor gene results from collaboration of complex series of positive and negative regulatory elements.

Authors:  H Itoh; N Inoue; D K Podolsky
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

7.  Induction of TFF1 gene expression in pancreas overexpressing transforming growth factor alpha.

Authors:  M P Ebert; J Hoffmann; C Haeckel; K Rutkowski; R M Schmid; M Wagner; G Adler; H U Schulz; A Roessner; W Hoffmann; P Malfertheiner
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

8.  PTPRF is disrupted in a patient with syndromic amastia.

Authors:  Surasawadee Ausavarat; Siraprapa Tongkobpetch; Verayuth Praphanphoj; Charan Mahatumarat; Nond Rojvachiranonda; Thiti Snabboon; Thomas C Markello; William A Gahl; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  BMC Med Genet       Date:  2011-03-31       Impact factor: 2.103

9.  cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis.

Authors:  H Itoh; M Tomita; H Uchino; T Kobayashi; H Kataoka; R Sekiya; Y Nawa
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

10.  Loss of anterior gradient 2 (Agr2) expression results in hyperplasia and defective lineage maturation in the murine stomach.

Authors:  Aparna Gupta; Dariusz Wodziak; May Tun; Donna M Bouley; Anson W Lowe
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.